MONOCLONAL GAMMOPATHY

Clinical trials for MONOCLONAL GAMMOPATHY explained in plain language.

Never miss a new study

Get alerted when new MONOCLONAL GAMMOPATHY trials appear

Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Can a cancer drug stop myeloma before it starts?

Disease control Ongoing

This phase 2 trial is testing the drug daratumumab in 42 people with high-risk MGUS or low-risk smoldering multiple myeloma—early, pre-cancerous conditions that can lead to multiple myeloma. The goal is to see if daratumumab can produce a deep response (very good partial response…

Matched conditions: MONOCLONAL GAMMOPATHY

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC

MONOCLONAL GAMMOPATHY

Get alerted when new MONOCLONAL GAMMOPATHY trials appear

Can a cancer drug stop myeloma before it starts?